(19)
(11) EP 3 986 888 A1

(12)

(43) Date of publication:
27.04.2022 Bulletin 2022/17

(21) Application number: 20734339.3

(22) Date of filing: 18.06.2020
(51) International Patent Classification (IPC): 
C07D 413/04(2006.01)
A01N 43/84(2006.01)
C07D 413/14(2006.01)
A01N 43/80(2006.01)
A01N 43/90(2006.01)
C07D 487/04(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 413/04; C07D 413/14; C07D 487/04; A01N 43/80; A01N 43/84; A01N 43/90
(86) International application number:
PCT/EP2020/066944
(87) International publication number:
WO 2020/254493 (24.12.2020 Gazette 2020/52)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 21.06.2019 EP 19181816

(71) Applicant: Bayer Aktiengesellschaft
51373 Leverkusen (DE)

(72) Inventors:
  • REBSTOCK, Anne-Sophie
    69410 CHAMPAGNE AU MONT D'OR (FR)
  • GENIX, Pierre
    69004 LYON (FR)
  • DESBORDES, Philippe
    69006 LYON (FR)
  • DUFOUR, Jeremy
    69003 LYON (FR)
  • COQUERON, Pierre-Yves
    69009 LYON (FR)
  • THOMAS, Vincent
    69003 LYON (FR)
  • DUCERF, Sophie
    69380 CHASSELAY (FR)

(74) Representative: BIP Patents 
c/o Bayer Intellectual Property GmbH Alfred-Nobel-Straße 10
40789 Monheim am Rhein
40789 Monheim am Rhein (DE)

   


(54) THIENYLHYDROXYISOXAZOLINES AND DERIVATIVES THEREOF